Federal regulators have approved the GLP-1 tablet Foundayo for weight loss. The once-daily oral pill provides an alternative ...

Police identify man killed in Antioch ...

Your iPhone can potentially save your life in emergencies. This video showcases 10 crucial features that may be vital in such ...

Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde. Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi. J&J hasn't announced how much Icotyde will ...

Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the lucrative psoriasis market with a new approval for a much-anticipated daily ...

Created by acclaimed Canadian filmmaker Aisling Chin-Yee, “The Pink Pill: Sex, Drugs & Who Has Control” unpacks a system of sex and gender-based discrimination pervasive throughout the medical field. ...

Is there one pill a day to keep me healthy? That's a question that Dr. Chloe Orkin hears a lot from her older HIV patients who take many medications each day to keep the virus under control. "They ...

The FDA approved Addyi, the first pill for low libido in women, boosting sexual desire. A Paramount+ documentary follows Cindy Eckert's campaign for FDA approval off Addyi Addyi improves sexual ...

Doctors call Wegovy's new weight loss pill a game changer in the fight against obesity, but some experts are urging patients to be cautious. Just weeks after hitting the market, nearly 200,000 people ...

On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide). The GLP-1 pill is still prescription-only, but ...

A month after drugmaker Novo Nordisk launched its Wegovy pill, online health and wellness company Hims & Hers plans to undercut it with a compounded semaglutide pill offered at a lower price. Hims & ...

Orforglipron is a promising weight loss pill that could be a huge growth catalyst for Eli Lilly. The Food and Drug Administration has pushed back the target action date on the drug by nearly two weeks ...